Burning Rock Biotech (BNR) Share-based Compensation (IS) (2020 - 2025)

Burning Rock Biotech (BNR) has reported Share-based Compensation (IS) for 6 consecutive years, with $625375.4 the latest figure, recorded in Q1 2025.

• In Q1 2025, Share-based Compensation (IS) fell 93.55% year-over-year to $625375.4; the TTM figure through Mar 2025 stood at $12.6 million (down 64.27% YoY), while the FY2024 annual figure was $1.1 million, down 88.95% from the prior year.
• Share-based Compensation (IS) came in at $625375.4 for Q1 2025 at Burning Rock Biotech, down from $1.1 million in the prior quarter.
• The five-year high for Share-based Compensation (IS) was $13.1 million in Q1 2021, with the low at $625375.4 in Q1 2025.
• Average Share-based Compensation (IS) over 5 years is $8.9 million, with a median of $9.9 million recorded in 2023.
• Across the five-year window, Share-based Compensation (IS) surged 2090.46% in 2021 and sank 93.55% in 2025, its largest moves.
• Year by year, Share-based Compensation (IS) stood at $9.5 million in 2021, then surged by 35.7% to $12.9 million in 2022, then declined by 23.11% to $9.9 million in 2023, then tumbled by 88.74% to $1.1 million in 2024, then plunged by 43.93% to $625375.4 in 2025.
• According to Business Quant data, Share-based Compensation (IS) over the past three periods registered $625375.4, $1.1 million, and $1.4 million for Q1 2025, Q4 2024, and Q3 2024 respectively.